From: An in vitro toolbox to accelerate anti-malarial drug discovery and development
Compound | HLM CLint (µL/min/mg)a | Unbound CLint (µL/min/mg) |
---|---|---|
Ionized or partially ionized bases at physiological pH | ||
Cycloguanil | < 7b | < 9.72c |
Doxycyclin | < 7b | < 7.53c |
Pyronaridine | 8.6 | 29.7 |
Proguanil | < 7b | < 21.2c |
Primaquine | 7.70 | 13.8 |
Chloroquine | < 7b | < 14c |
Chlorproguanil | < 7b | < 135c |
Azithromycin | < 7b | < 10c |
AQ-13 | < 7b | < 10.6c |
Desethylamodiaquine | 13.3 | CNDd |
Quinine | 16.5 | 28.9 |
Clindamycin | 32.0 | 47.8 |
KAF156 | 14.7 | 105 |
M5717 | 11.1 | 22.2 |
OZ277 | < 7b | < 159 |
Mefloquine | < 7b | < 140c |
Amodiaquine | 308 | 339 |
NPC1161B | < 7b | CND |
Ferroquine | 29.2 | 108 |
Naphthoquine | 14.4 | 68.6 |
Tafenoquine | < 7b | < 3500c |
MMV253 | 13.2 | 120 |
MMV052 | 13.0 | 13,000 |
Piperaquine | 20.1 | 1540 |
Halofantrine | 26.9 | 13,500 |
TDD-E209 | 25.5e | 85,000 |
Lumefantrine | < 7b | CNDd |
Ionized acids at physiological pH | ||
Sulfadoxine | < 7b | < 7.53 |
Sulfamethoxazole | < 7b | < 7.00 |
Artesunate | 146 | CNDd |
Atovaquone | < 7b | < 3500c |
Zwitterionic or partially zwitterionic at physiological pH | ||
P218 | < 7b | < 7.95c |
JPC3210 | 9.50 | 328 |
Neutral at physiological pH | ||
Dapsone | < 7b | < 8.14c |
Dihydroartemisinin | 16.6 | 19.1 |
DSM421 | < 7b | < 9.09c |
Pyrimethamine | < 7b | < 13c |
MMV048 | < 7b | < 11.5c |
Artemisone | 97.7 | 222 |
Artemether | 163 | 326 |
SJ733 | 142 | 245 |
DSM265 | < 7b,e | < 25c |
KAE609 | 24.1 | 1270 |
OZ439 | 72.1 | 72,100 |
ELQ300 | < 7b | < 3500c |